Real Estate Archives - Page 20 of 27 - Boston Life Sciences Times

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

March 3, 2026

THIS WEEK'S STORIES

Allurion to Appeal NYSE Delisting Notice, Outlines Plan to Regain Compliance

March 2, 2026

Physicians Increasingly Concerned About Affordable Healthcare Access, athenahealth Survey Finds

March 4, 2026

Response Pharmaceuticals Reports Positive Phase 2 Data for RDX-002 in Post-GLP-1 Weight Management

March 5, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Real Estate

Thermo Fisher Scientific Opens Cryo-Electron Microscopy Drug Discovery Center in South San Francisco

Solect Energy Highlights Rooftop Solar Site Leases as New Revenue Stream for Commercial Property Owners

CordenPharma Colorado Expands Peptide Development Operations with New Lease at Boulder’s Flatiron Park

Boston Reclaims Top Spot in U.S. Life Sciences Leasing as Market Stabilizes

BioMed Realty’s Gateway of Pacific Wins BOMA TOBY Award for Excellence in Life Science Operations

Most Read

Response Pharmaceuticals Reports Positive Phase 2 Data for RDX-002 in Post-GLP-1 Weight Management

Proxima Appoints Three Scientists to Advisory Board to Advance Proximity Therapeutics Platform

Harrison.ai Receives FDA Clearance for AI Tool to Triage Acute Infarcts on Non-Contrast CT Brain Scans

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

EDITOR PICKS

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

THIS WEEK'S STORIES

Allurion to Appeal NYSE Delisting Notice, Outlines Plan to Regain Compliance

Physicians Increasingly Concerned About Affordable Healthcare Access, athenahealth Survey Finds

Response Pharmaceuticals Reports Positive Phase 2 Data for RDX-002 in Post-GLP-1 Weight Management

POPULAR CATEGORY

ABOUT US

FOLLOW US